Natco Of India Launches Bone-Cancer Generic It Sees As Blockbuster
This article was originally published in PharmAsia News
Executive SummaryIndia's Natco Pharma has launched at home its generic of Treanda (bendamustine), U.S.-based Cephalon's drug to treat cancer of the soft tissue in bones
You may also be interested in...
A collaboration between Novo and Fauna will look at animal hibernation and genetic sequencing for hints toward novel therapies for obesity. Pfizer will use Insilico’s machine learning technology in target validation.